These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 17931768

  • 1. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG.
    Cancer Lett; 2007 Dec 18; 258(2):189-98. PubMed ID: 17931768
    [Abstract] [Full Text] [Related]

  • 2. Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model.
    Kim HS, Kim CH, Park MY, Park JS, Park HM, Sohn HJ, Kim HJ, Kim SG, Oh ST, Kim TG.
    Immunol Lett; 2010 Jun 15; 131(1):73-80. PubMed ID: 20211203
    [Abstract] [Full Text] [Related]

  • 3. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM, Zheng SE, Bader A, Yao HP, Wu NP, Altmeyer P, Brockmeyer NH, Jin J.
    Eur J Med Res; 2008 Jan 23; 13(1):7-14. PubMed ID: 18226991
    [Abstract] [Full Text] [Related]

  • 4. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
    Weigel BJ, Panoskaltsis-Mortari A, Diers M, Garcia M, Lees C, Krieg AM, Chen W, Blazar BR.
    Exp Hematol; 2006 Oct 23; 34(10):1403-12. PubMed ID: 16982333
    [Abstract] [Full Text] [Related]

  • 5. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.
    J Immunother; 2007 Oct 23; 30(8):789-97. PubMed ID: 18049330
    [Abstract] [Full Text] [Related]

  • 6. Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.
    Ziske C, Etzrodt PE, Eliu AS, Gorschlüter M, Strehl J, Flieger D, Messmer D, Schmitz V, Gonzalez-Carmona MA, Sievers E, Brossart P, Sauerbruch T, Schmidt-Wolf IG.
    Pancreas; 2009 Oct 23; 38(7):758-65. PubMed ID: 19546834
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 23; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 8. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Dec 23; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y, Huang H, Chen Z, Zong L, Xiang J.
    J Gene Med; 2003 Aug 23; 5(8):668-80. PubMed ID: 12898636
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
    Xie J, Xiong L, Tao X, Li X, Su Y, Hou X, Shi H.
    Lung Cancer; 2010 Jun 23; 68(3):338-45. PubMed ID: 19671483
    [Abstract] [Full Text] [Related]

  • 11. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH, Wan YH.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):399-403. PubMed ID: 17456382
    [Abstract] [Full Text] [Related]

  • 12. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 13. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 15; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

  • 14. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG, Park MY, Kim CH, Sohn HJ, Kim HS, Park JS, Kim HJ, Oh ST, Kim TG.
    Vaccine; 2008 Nov 25; 26(50):6433-40. PubMed ID: 18812201
    [Abstract] [Full Text] [Related]

  • 15. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD, Luo RC, Ding ZH, Lu F, Yuan CQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug 25; 26(8):1184-7. PubMed ID: 16939917
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J.
    Clin Immunol; 2004 Jul 25; 112(1):35-44. PubMed ID: 15207780
    [Abstract] [Full Text] [Related]

  • 17. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors.
    Nagaraj S, Pisarev V, Kinarsky L, Sherman S, Muro-Cacho C, Altieri DC, Gabrilovich DI.
    J Immunother; 2007 Mar 15; 30(2):169-79. PubMed ID: 17471164
    [Abstract] [Full Text] [Related]

  • 19. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.
    Oncol Rep; 2007 Apr 15; 17(4):895-902. PubMed ID: 17342333
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
    Yang W, Feng J, Chang X, Fu T, Ye X, Zhang H, Li X, Wen H, Feng L, Tong C, Cui H.
    Gynecol Oncol; 2007 Apr 15; 105(1):238-43. PubMed ID: 17383546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.